Eurofins Dermscan Pharmascan

Eurofins Dermscan Pharmascan is a leading Contract Research Organization (CRO) specializing in clinical evaluation and laboratory testing for the cosmetic, personal care, and pharmaceutical industries. Following its acquisition by Eurofins Scientific in 2018, the company provides a comprehensive range of clinical trials to assess the safety, efficacy, and tolerance of dermo-cosmetic products and pharmaceutical treatments. Their expertise spans dermatology, ophthalmology, and pediatrics, utilizing advanced imaging and bio-analysis technologies. The company operates multiple clinical centers globally, offering services from early-phase safety studies to late-stage efficacy trials. They support clients with bio-metrological assessments, consumer tests, and regulatory documentation for global market access.